PWMG
ITCI

Prestige Wealth Management Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Prestige Wealth Management Group’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-42
Closed -$2.22K – 1166
2022
Q4 		$2.22K Buy
+42
New +$2.22K ﹤0.01% 809